good afterhours news
Leading Island's most active list, Rambus reported first-quarter earnings of 6 cents a share, compared with 12 cents in the year-ago period. The memory chip-design company had been expected to report earnings of 4 cents a share, according to a survey of analysts by Thomson Financial/First Call. Rambus shares (RMBS: news, chart, profile) rose 4 cents to close at $8.59 in regular Nasdaq trading and popped 8 percent higher after the earnings news hit the wire. See full story.
Riding a winning streak capped by an SG Cowen upgrade on Wednesday, Rational Software (RATL: news, chart, profile) reported third-quarter earnings of $13.3 million, or 7 cents a share, vs. the year-ago pro forma total of $40.2 million, or 20 cents a share. Analysts expected a profit of 6 cents a share. Revenue totaled $170.2 million, down from the year-ago total of $215.5 million. Analysts were looking for an estimated $164 million. Including one-time items, the company lost $17.9 million, or 9 cents a share, for the latest quarter. Shares nudged up 33 cents to $22.17 ahead of the report and managed a minimal move north in evening session.
Also reporting to the upside, Acclaim Entertainment posted earnings of 21 cents a share, in line with consensus estimates and up from 18 cents a share a year ago. Revenue came in at $81 million, a 13 percent increase from $72 million a year earlier. The video game-maker also said it now expects revenue of $65 million in this quarter, versus a prior estimate of $60 million. Shares of Acclaim (AKLM: news, chart, profile) traded down 12 cents to $4.87 ahead of the report but caught a wave of after-hours buyers, gather 18 percent as night fell.
On a disappointing note, Cree, Inc., reported second-quarter earnings of $5.84 million, or 8 cents a share, excluding one-time items, less than the 9 cents a share analysts had expected. In the year-ago period, the semiconductor firm earned $13.9 million, or 18 cents a share. Revenue totaled $41 million, compared with the year-ago total of $41.5 million. Shares (CREE: news, chart, profile) closed down 57 cents to $30.65 ahead of the news before falling 8 percent more after the close.
Tech overview
Highlighting after-hours bullishness, IGEN International (IGEN: news, chart, profile) said Thursday a jury has awarded the company $505 million in damages in its case against Roche Diagnostics, a division of European pharmaceutical company Roche. IGEN said the jury found Roche had breached a license agreement related to medical diagnostics. Shares of IGEN were off 82 cents to $38.09 to end the day, but exploded for a 27 percent gain in the evening session. |
